Research progress of MEK1/2 inhibitors and degraders in the treatment of cancer
Chao Wang, Han Wang, Cangxin Zheng, Zhenming Liu, X. Gao, Fengrong Xu, Yan Niu, Liangren Zhang, Ping Xu
Topics & Concepts
MAPK/ERK pathwayKinaseChemistryProtein kinase AProteolysisMEK inhibitorCancer researchCell biologyEnzymeBiologyBiochemistryProtein Degradation and InhibitorsMelanoma and MAPK PathwaysMultiple Myeloma Research and Treatments